The 30-Day Follow-up of the Pancreas Cohort of the SHIELDS Trial (Safety and Performance of a Synthetic Tissue Sealant in Reducing Fluid Leakage Following Elective Hepatobiliary and Pancreatic Surgery). (2022) - Goetz, M.